Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
25.36
-0.59 (-2.27%)
Mar 9, 2026, 1:19 PM EDT - Market open
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $3.70 billion as of March 9, 2026. Its market cap has increased by 67.74% in one year.
Market Cap
3.70B
Enterprise Value
3.66B
1-Year Change
67.74%
Ranking
Category
Stock Price
$25.36
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $3.70B, an increase of 111.87%. That is a compound annual growth rate of 17.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.79B | 3.76% |
| Dec 31, 2025 | 3.65B | 65.43% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Structure Therapeutics | 4.09B |
| Ligand Pharmaceuticals | 4.03B |
| Crinetics Pharmaceuticals | 4.00B |
| Viking Therapeutics | 3.81B |
| ACADIA Pharmaceuticals | 3.78B |
| ADMA Biologics | 3.67B |
| Corcept Therapeutics | 3.60B |
| Legend Biotech | 3.50B |